Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of IC51 (Ixiaro) Vaccine Batch Over Shelf-Life
NCT00776230Phase 3Completed
- Sponsor
- Valneva
- Start
- Sep 2008
- Primary completion
- Jun 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
Phase 3, open-label trial of Japanese encephalitis inactivated vaccine in Japanese encephalitis (JE) (3 arms), sponsored by Valneva. Primary endpoint: Geometric Mean Titers at Day 56. Started Sep 2008; status: completed.
02
Drugs
Japanese encephalitis inactivated vaccine
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on NCT00776230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00776230.